Center for Nerve Engineering, Department of Pharmacology, UCL School of Pharmacy, University College London, London, United Kingdom.
Department of Pharmacology, UCL School of Pharmacy, University College London, London, United Kingdom.
Tissue Eng Part B Rev. 2022 Oct;28(5):1137-1150. doi: 10.1089/ten.TEB.2021.0159. Epub 2022 Apr 4.
The peripheral nervous system has the remarkable ability to regenerate in response to injury. However, this is only successful over shorter nerve gaps and often provides poor outcomes for patients. Currently, the gold standard of treatment is the surgical intervention of an autograft, whereby patient tissue is harvested and transplanted to bridge the nerve gap. Despite being the gold standard, more than half of patients have dissatisfactory functional recovery after an autograft. Peripheral nerve tissue engineering aims to create biomaterials that can therapeutically surpass the autograft. Current tissue-engineered constructs are designed to deliver a combination of therapeutic benefits to the regenerating nerve, such as supportive cells, alignment, extracellular matrix, soluble factors, immunosuppressants, and other therapies. An emerging therapeutic opportunity in nerve tissue engineering is the use of electrical stimulation (ES) to modify and enhance cell function. ES has been shown to positively affect four key cell types, such as neurons, endothelial cells, macrophages, and Schwann cells, involved in peripheral nerve repair. Changes elicited include faster neurite extension, cellular alignment, and changes in cell phenotype associated with improved regeneration and functional recovery. This review considers the relevant modes of administration and cellular responses that could underpin incorporation of ES into nerve tissue engineering strategies. Impact Statement Tissue engineering is becoming increasingly complex, with multiple therapeutic modalities often included within the final tissue-engineered construct. Electrical stimulation (ES) is emerging as a viable therapeutic intervention to be included within peripheral nerve tissue engineering strategies; however, to date, there have been no review articles that collate the information regarding the effects of ES on key cell within peripheral nerve injury. This review article aims to inform the field on the different therapeutic effects that may be achieved by using ES and how they may become incorporated into existing strategies.
周围神经系统具有响应损伤而再生的显著能力。然而,这仅在较短的神经间隙中才成功,并且常常为患者提供较差的结果。目前,治疗的金标准是自体移植物的手术干预,即从患者身上采集组织并移植以桥接神经间隙。尽管是金标准,但超过一半的患者在接受自体移植物后功能恢复不满意。周围神经组织工程旨在创建具有治疗潜力的生物材料,以超越自体移植物。目前的组织工程构建体旨在为再生神经提供多种治疗益处,例如支持细胞、对齐、细胞外基质、可溶性因子、免疫抑制剂和其他疗法。神经组织工程中的一个新兴治疗机会是使用电刺激 (ES) 来修饰和增强细胞功能。研究表明,ES 可积极影响参与周围神经修复的四种关键细胞类型,如神经元、内皮细胞、巨噬细胞和施万细胞。引发的变化包括更快的神经突延伸、细胞对齐以及与改善再生和功能恢复相关的细胞表型变化。本综述考虑了相关的给药方式和细胞反应,这些反应可能为将 ES 纳入神经组织工程策略提供依据。
影响说明组织工程变得越来越复杂,通常在最终的组织工程构建体中包含多种治疗方式。电刺激 (ES) 作为一种可行的治疗干预措施,正在被纳入周围神经组织工程策略中;然而,迄今为止,还没有综述文章将 ES 对周围神经损伤中关键细胞的影响信息进行汇总。这篇综述文章旨在为该领域提供有关使用 ES 可能实现的不同治疗效果的信息,以及它们如何被纳入现有的策略中。